(Q74227547)

English

The rationale for the use of anabolic steroids in controlling the adverse effects of corticoid hormones upon protein and osseous tissues

scientific article published on 01 September 1956

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13360459

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13360459%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

title

The rationale for the use of anabolic steroids in controlling the adverse effects of corticoid hormones upon protein and osseous tissues (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13360459

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13360459%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

author

Edward Conrad Reifenstein

series ordinal

1

object named as

E C REIFENSTEIN

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13360459

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13360459%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

language of work or name

English

1 reference

inferred from

Southern Medical Journal

publication date

1 September 1956

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13360459

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13360459%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

published in

Southern Medical Journal

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13360459

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13360459%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

volume

49

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13360459

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13360459%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13360459

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13360459%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

page(s)

933-960

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13360459

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13360459%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

Identifiers

DOI

10.1097/00007611-195609000-00001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13360459

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13360459%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 November 2019

PubMed publication ID

13360459

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13360459

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13360459%20AND%20SRC:MED&resulttype=core&format=json

(Q74227547)

The rationale for the use of anabolic steroids in controlling the adverse effects of corticoid hormones upon protein and osseous tissues

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)